Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades

Analysts at Goldman Sachs downgraded Cisco Systems, Inc. (NASDAQ: CSCO) from Buy to Neutral. The target price for Cisco has been lowered from $35 to $32. Cisco shares fell 1.59 percent to $28.50 in pre-market trading.

Morgan Stanley downgraded Infinity Pharmaceuticals Inc. (NASDAQ: INFI) from Overweight to Equal-weight. The target price for Infinity Pharmaceuticals has been lowered from $11 to $1. Infinity Pharmaceuticals shares dipped 6.62 percent to $1.27 in pre-market trading.

Analysts at RBC Capital downgraded LinkedIn Corp (NYSE: LNKD) from Outperform to Sector Perform. The target price for LinkedIn has been raised from $160 to $196. LinkedIn shares gained 0.06 percent to $191.75 in pre-market trading.

H.C. Wainwright downgraded United Therapeutics Corporation (NASDAQ: UTHR) from Buy to Neutral. The target price for United Therapeutics has been lowered from $175 to $95. United Therapeutics shares declined 2.21 percent to $104.89 in pre-market trading.

Analysts at JMP Securities downgraded Marketo Inc (NASDAQ: MKTO) from Market Outperform to Market Perform. Marketo shares rose 0.03 percent to close at $35.06 on Tuesday.

Credit Suisse downgraded Tesoro Corporation (NYSE: TSO) from Outperform to Neutral. The target price for Tesoro has been lowered from $100 to $90. Tesoro shares dropped 0.59 percent to $72.28 in pre-market trading.

Analysts at KeyBanc downgraded Compass Minerals International, Inc. (NYSE: CMP) from Overweight to Sector Weight. Compass Minerals shares rose 0.32 percent to close at $78.34 on Tuesday.

Avondale Partners downgraded Broadridge Financial Solutions, Inc. (NYSE: BR) from Market Outperform to Market Perform. The target price for Broadridge Financial is set to $65. Broadridge Financial shares dropped 0.48 percent to close at $63.97 on Monday.

Cowen & Company downgraded LDR Holding Corp (NASDAQ: LDRH) from Outperform to Market Perform. LDR Holding shares rose 0.16 percent to $36.96 in pre-market trading.

Barrington Research downgraded Cimpress NV (NASDAQ: CMPR) from Outperform to Market Perform. Cimpress shares fell 0.73 percent to $93.28 in pre-market trading.

Latest Ratings for CSCO

DateFirmActionFromTo
Nov 2019MaintainsBuy
Nov 2019MaintainsOverweight
Nov 2019MaintainsOutperform

View More Analyst Ratings for CSCO
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (BR + CMP)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
TORCCantor FitzgeraldDowngrades3.0
CIDMCanaccord GenuityMaintains1.5
TDGCanaccord GenuityMaintains620.0
DLPNCanaccord GenuityMaintains1.6
WBCLSADowngrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

The Market In 5 Minutes: Janet Yellen, Exact Sciences And Some Graduation Advice

Argus Is Bullish On Monsanto Regardless Of Merger Talk Outcome